Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

NCT03469557

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
Locations
  • Fifth Medical Center of Pla General Hospital Beijing, Beijing Municipality, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
  • Northern Jiangsu Peoples Hospital Yangzhou, Jiangsu, China
View Trial Details
Completed

A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

NCT04144517

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Mural Oncology Investigational Site Miami, Florida, United States
  • Mural Oncology Investigational Site Atlanta, Georgia, United States
  • Mural Oncology Investigational Site Minneapolis, Minnesota, United States
  • Mural Oncology Investigational Site New York, United States
View Trial Details
Completed

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

NCT03565003

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chinese PLA Central Hospital Beijing, Beijing Municipality, China
View Trial Details
Completed

A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer

NCT04474470

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colorectal Adenocarcinoma, +14 more
Locations
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSD Moores Cancer Center San Diego, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View Trial Details
Completed

WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer

NCT03028766

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations
  • University Hospital Birmingham Nhs Foundation Trust Birmingham, West Midlands, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • St. James' University Hospital, Leeds Teaching Hospital NHS Trust Leeds, United Kingdom
  • The Royal Marsden Hospital London, United Kingdom
View Trial Details

Related conditions